Skip to main content

Wounds and Injuries

2
Pipeline Programs
14
Companies
14
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

12 companies ranked by most advanced pipeline stage

Biocorp
BiocorpFrance - Issoire
1 program
1
AR/101Phase 21 trial
Active Trials
NCT02602184Unknown18Est. Jun 2017
Tissue Repair
Tissue RepairAustralia - Sydney
1 program
1
GAM501Phase 11 trial
Active Trials
NCT00065663Completed21Est. Dec 2004
Alliance Pharmaceuticals
2 programs
International Kink Health StudyN/A1 trial
Monitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult ContextsN/A1 trial
Active Trials
NCT05318053Completed917Est. Mar 2024
NCT01779011Completed305Est. May 2012
Solventum
SolventumMN - St. Paul
2 programs
Negative Pressure Therapy w/ instillation and dwellN/A1 trial
V.A.C.Ulta with Prontosan instillationN/A1 trial
Active Trials
NCT03722485Terminated44Est. Apr 2022
NCT01867580Completed181Est. Nov 2015
Zoll
ZollCA - San Jose
1 program
Closed Loop Control VentilationN/A1 trial
Active Trials
NCT02810080Completed210Est. Dec 2020
Crescent Biopharma
1 program
InfectedN/A1 trial
Active Trials
NCT03463720Completed843Est. May 2012
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
Integra™ dermal regeneration templateN/A1 trial
Active Trials
NCT04543240Unknown54Est. Jan 2021
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
InterventionN/A1 trial
Active Trials
NCT02113371Completed210Est. Sep 2016
Syneos Health
Syneos HealthNC - Morrisville
1 program
MAR-CUTISN/A1 trial
Active Trials
NCT03688880Terminated107Est. Sep 2019
Imbed Biosciences
Imbed BiosciencesWI - Middleton
1 program
Microlyte® MatrixN/A1 trial
Active Trials
NCT05439746Unknown53Est. Jan 2024
Bayer
BayerLEVERKUSEN, Germany
1 program
Plasmalyte AN/A1 trial
Active Trials
NCT01270854Completed46Est. Apr 2012
Stratpharma
StratpharmaSwitzerland - Basel
1 program
Treatment - StratamedN/A1 trial
Active Trials
NCT03843996Completed20Est. Jan 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BiocorpAR/101
Tissue RepairGAM501
Imbed BiosciencesMicrolyte® Matrix
Alliance PharmaceuticalsInternational Kink Health Study
SolventumNegative Pressure Therapy w/ instillation and dwell
Syneos HealthMAR-CUTIS
StratpharmaTreatment - Stratamed
Integra LifeSciencesIntegra™ dermal regeneration template
ZollClosed Loop Control Ventilation
SolventumV.A.C.Ulta with Prontosan instillation
Oregon TherapeuticsIntervention
BayerPlasmalyte A
Alliance PharmaceuticalsMonitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult Contexts
Crescent BiopharmaInfected

Clinical Trials (14)

Total enrollment: 3,029 patients across 14 trials

Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds

Start: Nov 2015Est. completion: Jun 201718 patients
Phase 2Unknown

Gene Therapy to Improve Wound Healing in Patients With Diabetes

Start: Aug 2002Est. completion: Dec 200421 patients
Phase 1Completed

A Study to Evaluate the Efficacy of Microlyte Matrix in the Management of Donor Site Wounds

Start: Jan 2023Est. completion: Jan 202453 patients
N/AUnknown
NCT05318053Alliance PharmaceuticalsInternational Kink Health Study

International Kink Health Study

Start: Jun 2022Est. completion: Mar 2024917 patients
N/ACompleted
NCT03722485SolventumNegative Pressure Therapy w/ instillation and dwell

Negative Pressure Wound Therapy With Instillation of Saline Solution Versus Collagenase Ointment in Full-thickness Wounds

Start: Dec 2018Est. completion: Apr 202244 patients
N/ATerminated

A Clinical Study to Compare MAR-CUTIS With Dermabond Advanced

Start: Oct 2018Est. completion: Sep 2019107 patients
N/ATerminated
NCT03843996StratpharmaTreatment - Stratamed

Comparison of a Novel Wound Dressing Stratamed Versus Current Clinical Practice After Follicular Unit Extraction Hair Transplantation

Start: Jan 2018Est. completion: Jan 201920 patients
N/ACompleted
NCT04543240Integra LifeSciencesIntegra™ dermal regeneration template

Bacterial Load for Integra™ in Operative Wounds

Start: Dec 2017Est. completion: Jan 202154 patients
N/AUnknown
NCT02810080ZollClosed Loop Control Ventilation

FiO2 Closed Loop Control Ventilation

Start: Dec 2016Est. completion: Dec 2020210 patients
N/ACompleted
NCT01867580SolventumV.A.C.Ulta with Prontosan instillation

A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement

Start: May 2013Est. completion: Nov 2015181 patients
N/ACompleted

Evaluation of COMmunity of Practice And Safety Support (COMPASS) for Home Care Workers

Start: Oct 2011Est. completion: Sep 2016210 patients
N/ACompleted
NCT01270854BayerPlasmalyte A

Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients

Start: Feb 2011Est. completion: Apr 201246 patients
N/ACompleted
NCT01779011Alliance PharmaceuticalsMonitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult Contexts

Monitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult Contexts

Start: Jan 2011Est. completion: May 2012305 patients
N/ACompleted

Outcome for Patients With War-Associated Extremity Wound Infection

Start: Sep 2010Est. completion: May 2012843 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

14 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.